These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin. Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170 [TBL] [Abstract][Full Text] [Related]
8. NF2: the wizardry of merlin. Xiao GH; Chernoff J; Testa JR Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate. Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations. Stokowski RP; Cox DR Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203 [TBL] [Abstract][Full Text] [Related]
11. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling. Kim S; Jho EH BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis. Petrilli A; Bott M; Fernández-Valle C Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290 [TBL] [Abstract][Full Text] [Related]
13. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1. Kissil JL; Wilker EW; Johnson KC; Eckman MS; Yaffe MB; Jacks T Mol Cell; 2003 Oct; 12(4):841-9. PubMed ID: 14580336 [TBL] [Abstract][Full Text] [Related]
14. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014 [TBL] [Abstract][Full Text] [Related]
15. The neurofibromatoses: when less is more. Gutmann DH Hum Mol Genet; 2001 Apr; 10(7):747-55. PubMed ID: 11257108 [TBL] [Abstract][Full Text] [Related]
16. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation. Huang J; Chen J Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868 [TBL] [Abstract][Full Text] [Related]
17. The molecular biology of NF2/Merlin on tumorigenesis and development. Vlashi R; Sun F; Zheng C; Zhang X; Liu J; Chen G FASEB J; 2024 Jul; 38(13):e23809. PubMed ID: 38967126 [TBL] [Abstract][Full Text] [Related]
18. Updates on Tumor Biology in Vestibular Schwannoma. Nourbakhsh A; Dinh CT Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611 [TBL] [Abstract][Full Text] [Related]
19. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function. Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154 [TBL] [Abstract][Full Text] [Related]